Reduce Validation Efforts Up to 70% In this webinar presented jointly by Axendia, Bigfinite, and Honeywell, we will discuss how companies are increasing quality and …
Webinar: Real-Time Operations Intelligence for Life Sciences Read More »
An Axendia Straight from the Source Webinar Disruption is on the radar! Life-Science executives must plot a course for success. That was the theme of …
2020 Life Science Radar – Webinar Registration is Open! Read More »
Veeva Summit 2019 Event Brief By: Daniel R. Matlis, President Veeva has become a strategic technology partner to more than 775 customers across the globe, …
Transforming Quality, a Top Priority for Customers at Veeva Summit 2019 Read More »
Recap of the Institute of Packaging Professionals (IoPP) – Puerto Rico Chapter Meeting On August 22, 2019, I was invited by the IoPP – Puerto …
What to Expect in FDA’s Draft Guidance on Computer Software Assurance Read More »
A Straight from the Source Webinar Available On-Demand FDA is encouraging the use of “Digital Evidence” to inform clinical trial design, predict clinical outcomes, support …
Regulatory Consideration for AI-Enabled QMS Life Science companies must adopt Predictive Quality. This eBook, sponsored by Sparta Systems, discusses how industry should leverage FDA’s Good Machine …
eBook: AI Drives Shift from Reactive to Predictive Quality Read More »
Dassault Systèmes Analyst Conference Brief 2019 By: Sandra K. Rodriguez, Market Analyst The news out of this years’ Dassault Systèmes Analyst Conference was huge: a …
Dassault Systèmes 3DExperience North America 2019 Forum Event Brief By: Daniel R. Matlis, President At this year’s 3DEXPERIENCE North America Forum, Dassault Systèmes continued to …
More Than Skin Deep: Dassault Systèmes is Transforming the Patient Experience Read More »
A Straight from the Source Webinar Available On-Demand FDA is encouraging the use of “Digital Evidence” to accelerate product innovation supporting rapid introduction of life-saving technology for patients. “Digital evidence” is already being used at FDA …
FDA Discusses the Use of Digital Evidence to Accelerate Innovation Read More »
An Excerpt from ISPE’s iSpeak Blog By: Sandra K. Rodriguez, Market Analyst “The FDA is witnessing a surge of cell and gene therapy products entering …
The Surge of CAR-T Products Drives Medicare to Evaluate Coverage Read More »
Q&A from an Axendia Straight from the Source (SftS) Webinar By: Francisco Vicenty, FDA, CDRH and Daniel R. Matlis, Axendia, President In our recent webinar, we …
FDA Answers Your Questions on the New Approach to CSV Read More »
Brand owners are legally responsible for the safety, efficacy and quality of their products By: Daniel R. Matlis, President The globalization of life science products …
Supply Chain Visibility: A Regulatory Necessity and Business Imperative Read More »
